Advanced company searchLink opens in new window

MEDOVATE LIMITED

Company number 10894990

Persons with significant control: 1 active person with significant control / 0 active statements

Lunovi Limited Active

Correspondence address
C/O Jeb Technologies Limited, Hampstead Avenue, Mildenhall, Suffolk, England, IP28 7AS
Notified on
25 October 2021
Governing law
Legal form
Place registered
Companies House
Registration number
09742722
Incorporated in
England
Nature of control
Ownership of shares – 75% or more
Ownership of voting rights - 75% or more

Mercia Fund Management Limited Ceased

Correspondence address
Forward House, 17 High Street, Henley-In-Arden, Warwickshre, United Kingdom, B95 5AA
Notified on
13 August 2021
Ceased on
2 November 2023
Governing law
Legal form
Place registered
Companies House
Registration number
06973399
Incorporated in
England And Wales
Nature of control
Ownership of voting rights - More than 25% but not more than 50%

Kelta Limited Ceased

Correspondence address
Eagle House, 28 Billing Road, Northampton, Northamptonshire, England, NN1 5AJ
Notified on
21 November 2017
Ceased on
25 October 2021
Governing law
Legal form
Place registered
England And Wales
Registration number
09231573
Incorporated in
England And Wales
Nature of control
Ownership of shares – More than 25% but not more than 50%
Ownership of voting rights - More than 25% but not more than 50%

Nvm Private Equity Llp Ceased

Correspondence address
Time Central, Gallowgate, Newcastle Upon Tyne, England, NE1 4SN
Notified on
21 November 2017
Ceased on
13 August 2021
Governing law
Legal form
Place registered
England
Registration number
Oc392261
Incorporated in
England
Nature of control
Ownership of voting rights - More than 25% but not more than 50%

Health Enterprise East Limited Ceased

Correspondence address
Milton Hall, Ely Road, Milton, Cambridge, United Kingdom, CB24 6WZ
Notified on
2 August 2017
Ceased on
13 August 2021
Governing law
Legal form
Place registered
England
Registration number
05285665
Incorporated in
England
Nature of control
Ownership of shares – More than 25% but not more than 50%
Ownership of voting rights - More than 25% but not more than 50%
Right to appoint or remove directors